Iradimed (NASDAQ:IRMD – Get Free Report) issued its quarterly earnings results on Thursday. The medical equipment provider reported $0.40 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.05), Zacks reports. Iradimed had a return on equity of 23.99% and a net margin of 26.12%. Iradimed updated its Q1 2025 guidance to 0.390-0.430 EPS and its FY 2025 guidance to 1.710-1.810 EPS.
Iradimed Trading Down 0.7 %
IRMD traded down $0.39 on Friday, hitting $55.02. 4,390 shares of the company’s stock were exchanged, compared to its average volume of 40,835. The firm has a market cap of $697.05 million, a PE ratio of 37.68 and a beta of 0.82. Iradimed has a twelve month low of $40.18 and a twelve month high of $63.29. The stock has a fifty day moving average of $57.16 and a two-hundred day moving average of $52.02.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Iradimed from a “strong-buy” rating to a “buy” rating in a research report on Thursday.
Insider Buying and Selling
In other Iradimed news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the sale, the chief financial officer now owns 4,383 shares in the company, valued at approximately $237,470.94. This trade represents a 36.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 37.10% of the stock is owned by company insiders.
Iradimed Company Profile
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Featured Articles
- Five stocks we like better than Iradimed
- What Are Dividends? Buy the Best Dividend Stocks
- Up 50% in January, Twilio’s Pullback is the Time to Buy
- What is a Special Dividend?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
- Best Stocks Under $5.00
- Cisco Roars Back: Is the Tech Giant Reborn?
Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.